posts browsing tag

Genome Asia 100K Initiative

– The largest number of regions and races included in any Asian reference panel – Identification of genome diversity within Asian ethnic groups and differences in drug response SEOUL, South Korea–The precision medicine and biotechnology company Macrogen (Chairman Jung-Sun Seo) (KOSDAQ: 038290) announced on Dec 4 that …

Continue reading

The unique genetic diversity that is prevalent in South, North, and East Asia provides a valuable source for clinical insights that will be able to enhance the understanding of disease biology. In order to help accelerate population specific precision medicine, Macrogen got involved with Genome Asia 100K in 2016, and …

Continue reading

Macrogen spearheads a revolution in healthcare based on preventative medicine In a country where the failure rate of start-ups has been traditionally high, Macrogen stands out as the first ever bio-venture company that has successfully expanded across the globe. Founding Chairman, Dr Jeong-Sun Seo, explains his vision …

Continue reading